First New York Securities’s Bausch Health BHC Stock Holding History

First New York Securities’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3	Closed	-$680	–	223
2016 Q1	$680	Buy	+3	New	+$222	﹤0.01%	236

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First New York Securities's BHC Position: Q4 2016 in Review

First New York Securities sold out of Bausch Health (BHC) in Q4 2016, closing a stake of 100 shares — an estimated $2.46K sold.

First New York Securities first reported a position in BHC in Q3 2014 and held it in 5 quarters. The position peaked at $274K in Q1 2016. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2016.

First New York Securities reported no remaining Bausch Health position as of Q4 2016 after selling out during the quarter.
First New York Securities sold 100 Bausch Health shares in Q4 2016, an estimated $2.46K.
First New York Securities first reported a position in Bausch Health in Q3 2014 and held it in 5 quarters.
First New York Securities's Bausch Health position peaked at $274K in Q1 2016.
315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.